Advocating for a world where intellectual
property law serves the public interest.

Senators Seek USTR Nominee Froman’s Views on IP, India, Trade Promotion Authority, & Transparency of TPP Negotiations

Last Thursday, the Senate Finance Committee held its confirmation hearing for the Obama Administration’s nominee for U.S. Trade Representative, Michael Froman. The hearing webpage has a webcast and prepared statements by Froman, as well as Chairman Baucus and Ranking Minority Leader Hatch. The opening statements were brief, so most of the hearing was Q&A. Themes […]

South to Introduce Resolution on Access to Medicines

(Reposted with permission from the TWN Info Service) Developing countries are set to introduce a resolution on access to medicines at the current session of the United Nations Human Rights Council. The 23rd regular session of the Human Rights Council is taking place from 27 May to 14 June in Geneva and the draft resolution […]

Facing Public Opposition, Taiwanese Government Withdraws SOPA-Like Copyright Legislation

The government of Taiwan has backed down from plans to amend its copyright law to justify take-downs of foreign websites accused of hosting copyright-infringing material. The Taiwan Intellectual Property Office (IPO) had proposed legislation to create a blacklist and allow DNS blocking. A citizen backlash sprung up immediately, and the IPO initially claimed the public […]

Rep. McDermott v. State Department – Conflicting Views on the Trans Pacific Parternship and Access to Medicines

Last week Jim McDermott wrote an op-ed in Roll Call on the TPP in which he warned that the U.S. proposal for intellectual property in the TPP could “cost millions of lives in developing countries.” McDermott wrote that the proposal extends patent monopolies on pharmaceuticals further than TRIPS: “It would extend patents beyond the current […]

Technical Note: The LDC TRIPS Transition Extension and the Question of Rollback

When the WTO agreements entered into force in 1995, least developed countries (LDCs) were given until 1 January 2006 to implement the obligations contained in the then-newly adopted TRIPS Agreement. In 2002, the LDC transition period was extended until 2016 for pharmaceutical patents, with a later decision in 2005 extending the period for all intellectual […]

Witnesses at U.S. Trade Hearing Offer Opinions (and Warnings) on Intellectual Property in Upcoming Negotiations with the EU

Today the Obama Administration’s inter-agency Trade Policy Staff Committee held the first day of its two-day hearing on the Transatlantic Trade and Investment Partnership (TTIP). Many of the witnesses who testified in the afternoon offered comments related to intellectual property and/or privacy on the internet – both subjects that are expected to be among the […]